KISQALI 200 mg/1

KISQALI 200 mg tablets are a prescription medication used in cancer treatment. This film-coated tablet is manufactured by Novartis Pharmaceuticals Corporation in the USA.

KISQALI 200 mg tablets are commonly used in combination with other medications for the treatment of certain types of cancer. The primary use of ribociclib is in the management of advanced breast cancer. Patients often wonder, 'What is KISQALI used for?' This medication is typically prescribed for specific cancer types and is taken orally.

Common effects of KISQALI 200 mg tablets may include fatigue, nausea, and diarrhea. Some users may experience hair loss or changes in appetite. It's important to note that individual responses to the medication can vary.

KISQALI 200 mg tablets should be handled with care and stored as directed. It is essential to follow the prescription guidelines provided by your healthcare provider. Always inform your doctor about any other medications you are taking to avoid potential interactions.

KISQALI 200 mg tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication. Always consult your healthcare provider before starting any new medication.